Skip to main content

Table 1 Sociodemographic and diagnostic variables in a population of adult patients with MPS IVA in Spain

From: Clinical features and health-related quality of life in adult patients with mucopolysaccharidosis IVA: the Spanish experience

Variable

Value (N = 33)

Age, median (IQR), years

32 (20.5–40.5)

Sex, n (%)

 

Men

17 (51.5)

Women

16 (48.5)

Height, median (range) (cm)

118 (106–136)

Men

126 (113.7–142.5)

Women

116 (105.2–124.7)

Weight, median (range) (kg)

34 (28–40)

Men

35.5 (30.9–49.7)

Women

31 (25.4–36.7)

Phenotype

 

Classical

18 (54.5)

Intermediate

11 (33.3)

Non-classical

4 (12.1)

BMI (kg/m2)

 

Classical phenotype

21.36 (18.23–25.30)

Intermediate phenotype

24.68 (23.36–31)

Non-classical phenotype

20.03 ( 16.31–26)

Consanguinity history, n (%)

3 (9)

Patients with affected siblings, n (%)

12 (36.6)

Age at diagnosis, years (IQR)

5.5 (2–12.6)

GAGs, mg/mmol creatinine (IQR)

22.60 (6.81–29.01)

Common GALNS mutations, n (%)

 

c.1156C > T

8 (24.2) [6 patients were homozygous]

c.901G > T

4 (12)

c.761A > G

2 (6) [both patients were homozygous]

First symptom at diagnosis, n (%)

 

Bone dysplasia

8 (24.2)

Kyphoscoliosis

5 (15.1)

  1. GAGs, glycosaminoglycans (keratan sulphate and chondroitin-6-sulphate); IQR, interquartile range; MPS, mucopolysaccharidosis